Why Space Biomanufacturing Is Becoming a Real Business

Lucas and Luna explore the emerging industry of space-based biomanufacturing — producing pharmaceuticals, proteins, and biomaterials in microgravity. They focus on a concrete case: Varda Space Industries' 2024 capsule that returned with crystals of the HIV drug ritonavir grown in orbit, showing better uniformity than Earth-made versions. The hosts discuss the business model: why the unique physics of microgravity allows for protein crystal growth that can improve drug efficacy and reduce costs. They examine the economics — a single orbital manufacturing run can produce high-value compounds worth millions, with launch costs dropping. Luna questions the scalability and regulatory hurdles, while Lucas points to NASA's ISS experiments that paved the way and the recent emergence of dedicated biomanufacturing startups. No hype — just the real numbers and strategic bets that could make this a viable new sector. #SpaceBiomanufacturing #Microgravity #Pharmaceuticals #ProteinCrystals #VardaSpace #DrugDevelopment #OrbitalManufacturing #SpaceEconomy #Biotech #ISS #Ritonavir #Business #Technology #SpaceBusiness #FexingoBusiness #BusinessPodcast #SpaceIndustry #CommercialSpace Keep every episode free: buymeacoffee.com/fexingo